These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors. Marona H, Szkaradek N, Kubacka M, Bednarski M, Filipek B, Cegla M, Szneler E. Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129 [Abstract] [Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity. Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B. Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527 [Abstract] [Full Text] [Related]
5. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors. Maciag D, Filipek B, Czekaj T, Marona H, Nowak G. Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970 [Abstract] [Full Text] [Related]
6. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone. Rapacz A, Pytka K, Sapa J, Kubacka M, Filipek B, Szkaradek N, Marona H. Eur J Pharmacol; 2014 Jul 15; 735():10-6. PubMed ID: 24751714 [Abstract] [Full Text] [Related]
12. Pharmacological properties of some aminoalkanolic derivatives of xanthone. Marona H, Pekala E, Filipek B, Maciag D, Szneler E. Pharmazie; 2001 Jul 15; 56(7):567-72. PubMed ID: 11487977 [Abstract] [Full Text] [Related]
13. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives. Dylag T, Zygmunt M, Maciag D, Handzlik J, Bednarski M, Filipek B, Kieć-Kononowicz K. Eur J Med Chem; 2004 Dec 15; 39(12):1013-27. PubMed ID: 15571863 [Abstract] [Full Text] [Related]
14. Synthesis and properties of some aminoalkanolic derivatives of xanthone. Marona H, Szneler E, Filipek B, Sapa J. Acta Pol Pharm; 1997 Dec 15; 54(1):63-70. PubMed ID: 9415200 [Abstract] [Full Text] [Related]
15. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity. Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B. Acta Pol Pharm; 2009 Dec 15; 66(6):649-62. PubMed ID: 20050529 [Abstract] [Full Text] [Related]